Furthermore, by pharmacological modulation of HO-1 in a human mixed primary cell culture of SCC, we confirm the above results, suggesting that HO-1 promotes HNSCC malignancy. The gene discussed is HMOX1; the disease is head and neck squamous cell carcinoma.